Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
An In-Silico Screening Strategy to the Prediction of New Inhibitors of Covid-19 Mpro Protein Publisher



Abbasi M1 ; Sadeghialiabadi H2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medicinal Chemistry, Faculty of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
  2. 2. Department of Medicinal Chemistry, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Iranian Journal of Pharmaceutical Research Published:2021


Abstract

The coronavirus disease-2019 (COVID-19) was first recognized in Wuhan, China, and quickly spread worldwide. Between all proposed research guidelines, inhibition of the main protease (Mpro) protein of the virus will be one of the main strategies for COVID-19 treatment. The present work was aimed to perform a computational study on FDA-approved drugs, similar to piperine scaffold, to find possible Mpro inhibitors. Firstly, virtual screening studies were performed on a library of FDA-approved drugs (43 medicinal compounds, similar to piperine scaffold). Among imported 43 drugs to virtual screening, 34 compounds were extracted. Four top-ranked drugs in terms of the highest interactions and the lowest binding energy were selected for the IFD study. Among these selections, lasofoxifene showed the lowest IFD score (-691.743 kcal mol-1). The stability of lasofoxifene in the COVID-19 Mpro protein active site was confirmed with 100 ns MD simulation. Lasofoxifene binding free energy was obtained-107.09 and-173.97 kcal mol-1, using Prime MM-GBSA and g_mmpbsa methods, respectively. The identified lasofoxifene by the presented computational approaches could be a suitable lead for inhibiting Mpro protein and COVID-19 treatment. © 2021, Briefland. All rights reserved.
Related Docs
View other Related Docs
1. Design and Synthesis of Novel Phe-Phe Hydroxyethylene Derivatives As Potential Coronavirus Main Protease Inhibitors, Journal of Biomolecular Structure and Dynamics (2022)
2. Prediction of Dual Nf-Κb/Iκb Inhibitors Using an Integrative In-Silico Approaches, Journal of Biomolecular Structure and Dynamics (2023)
3. Identification of New Small Molecules As Dual Foxm1 and Hsp70 Inhibitors Using Computational Methods, Research in Pharmaceutical Sciences (2022)
4. Identification of New Hsp90 Inhibitors: Structure Based Virtual Screening, Molecular Dynamic Simulation, Synthesis and Biological Evaluation, Anti-Cancer Agents in Medicinal Chemistry (2021)
5. 3D-Qsar, Molecular Docking, and Molecular Dynamic Simulations for Prediction of New Hsp90 Inhibitors Based on Isoxazole Scaffold, Journal of Biomolecular Structure and Dynamics (2018)
6. New Heat Shock Protein (Hsp90) Inhibitors, Designed by Pharmacophore Modeling and Virtual Screening: Synthesis, Biological Evaluation and Molecular Dynamics Studies, Journal of Biomolecular Structure and Dynamics (2020)
7. Prediction of New Hsp90 Inhibitors Based on 3,4-Isoxazolediamide Scaffold Using Qsar Study, Molecular Docking and Molecular Dynamic Simulation, DARU, Journal of Pharmaceutical Sciences (2017)
8. Prediction of Dual Agents As an Activator of Mutant P53 and Inhibitor of Hsp90 by Docking, Molecular Dynamic Simulation and Virtual Screening, Journal of Molecular Graphics and Modelling (2015)
Experts (# of related papers)
View all Related Experts
Afshin Fassihi (17)
Lotfollah Saghaie Dehkordi (11)
Other Related Docs
9. Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel Sars-Cov-2 Nsp3 Mac1 Domain Inhibitors, Viruses (2023)
10. Novel Drug Design for Treatment of Covid-19: A Systematic Review of Preclinical Studies, Canadian Journal of Infectious Diseases and Medical Microbiology (2022)
11. An Integrated in Silico Screening Strategy for Identifying Promising Disruptors of P53-Mdm2 Interaction, Computational Biology and Chemistry (2019)
12. Towards Screening and Repurposing of Approved Drugs for the Treatment of Covid-19 Using Molecular Docking, Physical Chemistry Research (2023)
13. Discovery of Novel Hit Compounds As Potential Hdac1 Inhibitors: The Case of Ligand- and Structure-Based Virtual Screening, Computers in Biology and Medicine (2021)
14. Novel 9-(Alkylthio)-Acenaphtho[1,2-E]-1,2,4-Triazine Derivatives: Synthesis, Cytotoxic Activity and Molecular Docking Studies on B-Cell Lymphoma 2 (Bcl-2), DARU, Journal of Pharmaceutical Sciences (2014)
15. Discovery of Novel Rarα Agonists Using Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Studies, PLoS ONE (2023)
16. Amyloid ß Fibril Disruption by Oleuropein Aglycone: Long-Time Molecular Dynamics Simulation to Gain Insight Into the Mechanism of Action of This Polyphenol From Extra Virgin Olive Oil, Food and Function (2020)
17. Pyrimido[4,5-B]Indole Derivatives Bearing 1,2,4-Oxadiazole Moiety As Mdm2 Inhibitor Candidates in Cancer Treatment, Future Medicinal Chemistry (2023)
18. Discovery of Novel Direct Small-Molecule Inhibitors Targeting Hif-2Α Using Structure-Based Virtual Screening, Molecular Dynamics Simulation, and Mm-Gbsa Calculations, Molecular Diversity (2024)
19. Design, Synthesis and Biological Studies of New Isoxazole Compounds As Potent Hsp90 Inhibitors, Scientific Reports (2024)
20. Sustainable Synthesis of Potential Antitumor New Derivatives of Abemaciclib and Fedratinib Via C-N Cross Coupling Reactions Using Pd/Cu-Free Co-Catalyst, Molecular Catalysis (2022)
21. Screening Efficacy of Available Hiv Protease Inhibitors on Covid-19 Protease, Journal of Military Medicine (2020)
22. Screening of Potential Inhibitors of Covid-19 With Repurposing Approach Via Molecular Docking, Network Modeling Analysis in Health Informatics and Bioinformatics (2022)
23. Hybrid Derivatives Containing Dimethyl Fumarate and Benzothiazole Scaffolds for the Potential Treatment of Multiple Sclerosis; in Silico & in Vivo Study, DARU, Journal of Pharmaceutical Sciences (2024)
24. Quantum Processing of Cytidine Derivatives and Evaluating Their in Silico Interactions With the Covid-19 Main Protease, Main Group Chemistry (2022)
25. Elucidation of Molecular Mechanisms Behind the Self-Assembly Behavior of Chitosan Amphiphilic Derivatives Through Experiment and Molecular Modeling, Pharmaceutical Research (2015)
26. Comparative Quantitative Structure-Activity Relationship Study of Some 1-Aminocyclopentyl-3-Carboxyamides As Ccr2 Inhibitors Using Stepwise Mlr, Fa-Mlr, and Ga-Pls, Medicinal Chemistry Research (2012)
27. In Silico Interactions of Some of the Triazole Derivatives With the Main Protease of Coronavirus, Biointerface Research in Applied Chemistry (2023)
28. Exploring the Interaction Between Epidermal Growth Factor Receptor Tyrosine Kinase and Some of the Synthesized Inhibitors Using Combination of In-Silico and In-Vitro Cytotoxicity Methods, Research in Pharmaceutical Sciences (2018)
29. Dihydropyrimidine Derivatives As Mdm2 Inhibitors, Chemical Biology and Drug Design (2024)
30. Molecular Dynamics Simulation of Chemokine Receptors in Lipid Bilayer: A Case Study on C-C Chemokine Receptor Type 2, Chemical Biology and Drug Design (2013)
31. Virtual Screening and Pharmacophore Design for a Novel Theoreticalinhibitor of Macrophage Stimulating Factor As a Metastatic Agent, BioImpacts (2013)
32. Insights Into the Human A1 Adenosine Receptor From Molecular Dynamics Simulation: Structural Study in the Presence of Lipid Membrane, Medicinal Chemistry Research (2015)
33. Exploring a Model of a Chemokine Receptor/Ligand Complex in an Explicit Membrane Environment by Molecular Dynamics Simulation: The Human Ccr1 Receptor, Journal of Chemical Information and Modeling (2011)
34. Preparing a Database of Corrected Protein Structures Important in Cell Signaling Pathways, Research in Pharmaceutical Sciences (2023)
35. In Silico Identification of Natural Products and World-Approved Drugs Targeting the Keap1/Nrf2 Pathway Endowed With Potential Antioxidant Profile, Computation (2023)
36. Therapeutic Targets of Natural Products for the Management of Cardiovascular Symptoms of Coronavirus Disease 2019, Phytotherapy Research (2021)
37. Gp41 Inhibitory Activity Prediction of Theaflavin Derivatives Using Ligand/Structure-Based Virtual Screening Approaches, Computational Biology and Chemistry (2019)
38. Qsar and Docking Studies of Some 1,2,3,4-Tetrahydropyrimidines: Evaluation of Gp41 As Possible Target for Anti-Hiv-1 Activity, Medicinal Chemistry Research (2015)
39. In Silico Investigation of Nanocarbon Biosensors for Diagnosis of Covid-19, Eurasian Chemical Communications (2021)
40. Disruption of Irisin Dimerization by Fda-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes, International Journal of Molecular Sciences (2023)
41. Virtual Screening for the Identification of Potential Candidate Molecules Against Envelope (E) and Membrane (M) Proteins of Sars-Cov-2, Journal of Computational Biophysics and Chemistry (2021)
42. In Silico Screening for Novel Tyrosine Kinase Inhibitors With Oxindole Scaffold As Anti-Cancer Agents: Design, Qsar Analysis, Molecular Docking and Admet Studies, Journal of Computational Biophysics and Chemistry (2022)
43. Homology Modeling of Human Ccr5 and Analysis of Its Binding Properties Through Molecular Docking and Molecular Dynamics Simulation, Biochimica et Biophysica Acta - Biomembranes (2011)
44. Synthesis, Biological Screening and Docking Study of Some Novel Pyra-Zolopyrano[2,3-B]Quinolin Derivatives As Potent Antibacterial Agents, Current Bioactive Compounds (2022)
45. Bioinformatic Screening of Compounds From Iranian Lamiaceae Family Members Against Sars-Cov-2 Spike Protein, Letters in Drug Design and Discovery (2023)
46. Molecular Modeling, Structure Activity Relationship and Immunomodulatory Properties of Some Lupeol Derivatives, Medicinal Chemistry Research (2013)
47. The Effect of Novel 3R,6R-Bis (4-Hydroxy Benzyl) Piperazine-2,5-Dione (Bhbppd) Derivatives on the Expression of Caspases in Gastric Cancer: A Molecular Docking and Dynamics Simulation, Arabian Journal of Chemistry (2023)
48. Hybrid Pharmacophore Design, Molecular Docking, Synthesis, and Biological Evaluation of Novel Aldimine-Type Schiff Base Derivatives As Tubulin Polymerization Inhibitor, Chemistry and Biodiversity (2018)
49. Effects of Curcumin-Piperine Co-Supplementation on Clinical Signs, Duration, Severity, and Inflammatory Factors in Patients With Covid-19: A Structured Summary of a Study Protocol for a Randomised Controlled Trial, Trials (2020)
50. Characterization of Adenosine Receptor in Its Native Environment: Insights From Molecular Dynamics Simulations of Palmitoylated/Glycosylated, Membrane-Integrated Human A2b Adenosine Receptor, Journal of Molecular Modeling (2012)